Literature DB >> 26617911

Primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck rarely involving epiglottis: clinicopathological, immunohistomchemical and genetic features of a case.

Jun Zhou1, Guannan Wang1, Dandan Zhang1, Yuhui Yin1, Xia Pang1, Jing Zhang1, Yanpin Zhang1, Wencai Li1.   

Abstract

A case of primary mucosal CD30-positive T-cell lymphoproliferative disorder of the head and neck rarely involving epiglottis in a 59-year-old male was reported. Histologically, the ulcerative mucosa was affected by sheets of mixed inflammatory infiltration, with scattered large atypical lymphoid cells arranging in an individual or small clusters with focal epidermotropism. Immunohistochemically, tumor cells were uniformly immunoreactive to antibodies against CD2, CD3, CD7, CD43, CD4, TIA-1, with a heterogeneous expression of CD30, but negative for CD20, CD79a, CD21, CD8, CD56, ALK, EMA, granzyme B. Epstein-Barr virus encoded RNA (EBER) were detected. Genetically, T-cell receptor (TCR) γ gene showed an oligoclonal rearrangement. This first case developing in epiglottis demonstrates mucosal CD30-positive T-cell lymphoproliferative disorders are characteristic of a broad clinicopathologic spectrum similar to the counterpart in the skin with a favorable prognosis.

Entities:  

Keywords:  CD30; T-cell lymphoproliferative disorder; TCR; head and neck; immunohistochemistry

Mesh:

Substances:

Year:  2015        PMID: 26617911      PMCID: PMC4637727     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  7 in total

Review 1.  Oral involvement in lymphomatoid papulosis. Report of two cases and review of the literature.

Authors:  Ramon M Pujol; M Pilar García Muret; Paula Bergua; Ramon Bordes; Agustí Alomar
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

2.  Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.

Authors:  Andrew P Sciallis; Mark E Law; David J Inwards; Rebecca F McClure; William R Macon; Paul J Kurtin; Ahmet Dogan; Andrew L Feldman
Journal:  Mod Pathol       Date:  2012-03-02       Impact factor: 7.842

3.  The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck.

Authors:  WeiGe Wang; Ying Cai; WeiQi Sheng; HongFen Lu; XiaoQiu Li
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-10-12

Review 4.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

5.  CD30-positive T-cell lymphoproliferative disorder of the oral mucosa--an indolent lesion: report of 4 cases.

Authors:  Monica Agarwal; Patrick Shenjere; Robert W Blewitt; Gillian Hall; Philip Sloan; N Pigadas; S Sankar Banerjee
Journal:  Int J Surg Pathol       Date:  2008-04-02       Impact factor: 1.271

6.  T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity.

Authors:  Catherine L Salisbury; Steven D Budnick; Shiyong Li
Journal:  Am J Clin Pathol       Date:  2009-11       Impact factor: 2.493

7.  Eosinophilic ulcer of the oral mucosa: a distinct entity or a non-specific reactive pattern?

Authors:  S Segura; R M Pujol
Journal:  Oral Dis       Date:  2008-05       Impact factor: 3.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.